Shang Hai Zheng Quan Bao·2025-12-05 20:27Core Viewpoint - The company, Shenzhen Hepalink Pharmaceutical Group Co., Ltd., has announced the extension of the duration of its second and third employee stock ownership plans during the 19th meeting of the sixth board of directors held on December 5, 2025 [2][3][6]. Group 1: Board Meeting Details - The 19th meeting of the sixth board of directors was held on December 5, 2025, with all 7 directors participating in the voting [2]. - The meeting was presided over by Chairman Li Li and complied with relevant laws and regulations [2]. Group 2: Resolutions Passed - The board approved the extension of the second employee stock ownership plan's duration, with a unanimous vote of 7 in favor [3]. - The board also approved the extension of the third employee stock ownership plan's duration, again with a unanimous vote of 7 in favor [4]. Group 3: Employee Stock Ownership Plans Overview - The second employee stock ownership plan was initially approved on December 12, 2016, with a duration of 36 months, set to expire on December 11, 2019 [6]. - The plan has been extended multiple times, with the latest extension pushing the expiration date to December 11, 2024, and currently has 15,118,035 shares remaining unsold, representing 73.32% of the total purchased shares [8]. - The third employee stock ownership plan was approved on December 28, 2018, with an initial duration of 24 months, set to expire on December 27, 2020 [9]. - Similar to the second plan, the third plan has also been extended multiple times, with the latest extension moving the expiration date to December 27, 2025, and currently holds all purchased shares unsold [10].